Celcuity Inc. (CELC) Forward P/S Multiple

Graphic logo of Celcuity (CELC)

An innovative live-cell testing method for precise therapy selection positions Celcuity Inc. (CELC) as a leader in oncology diagnostics. The future significance of the P/S multiple visualizes market expectations, where the metric captures the current valuation. Robotic laboratories in the US ensure stability, while a high reputation in molecular oncology confirms its status as a reliable analysis standard, providing a fundamental basis for the price action.

CELC celcuity.com: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/13/2026

CELC (Celcuity Therapeutics): analytical breakdowns and indicator data

- market price and analyst price targets:
Price Chart Celcuity|CELC - Analyst Median Target
- market capitalization details:
Market Capitalization Celcuity Therapeutics|CELC - Company Buyout Price
- issuer book value statistics:
Net Assets per Single Share Celcuity|CELC - Book Valuation of Business|Market Capitalization to Book Value Ratio celcuity.com|CELC - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Celcuity Inc.|CELC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Celcuity Inc.|CELC - Company Debts|Debts to Book Capitalization Celcuity Therapeutics|CELC - Company Long-Term Liabilities|Company Current Liabilities Celcuity|Quick Ratio celcuity.com
- business earnings and investment ratios data:
CELC - Net Financial Result|Future Profit Celcuity Inc.|CELC - Market Price to Net Income Ratio|Projected Price to Earnings Celcuity Corp|CELC - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Celcuity Therapeutics|CELC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Celcuity|CELC - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months celcuity.com|CELC - Earnings per share growth this year|Earnings growth forecast for next year Celcuity Inc.
- sales volume and revenue indicators:
CELC - Company Sales|Company Future Sales Volume Celcuity|CELC - Price-to-Revenue Coefficient|Forward P/S Multiple Celcuity Therapeutics
Summary company analytics:Celcuity CELC
Product sample of Celcuity Inc.

The high cost of Celcuity Inc. (CELC) targeted therapy diagnostics embeds premium potential into future cash flows, which is directly reflected in market expectations. Analyzing the forward P/S trend, an investor can see the ratio of current market capitalization to projected revenue, where an excessive spike in the chart signals price overheating and the risk of a deep correction should trading liquidity decline.

Competitors of Celcuity Inc. (CELC)

Price-to-Projected Revenue Ratio Caris Life Sciences CAI|Market Cap to Expected Sales Ratio Guardant Health Inc (GH)|Veracyte Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio GRAIL Bio GRAL|Myriad Genetics, Inc. (MYGN) - Price-to-Projected Revenue Ratio|CSTL - Market Cap to Expected Sales Ratio|BNR (Burning Rock) - Forward P/S Multiple|Forward Price-to-Revenue Multiple VolitionRx Ltd (VNRX)|Forward P/S Multiple BDSX|PRPO - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Check-Cap CHEK|Mainz Biomed NV - Price-to-Projected Revenue Ratio|OncoCyte - Forward P/S Multiple